Latest Articles
Say no to pain, period: Stigma delaying endometriosis treatment - MSN
Say no to pain, period: Stigma delaying endometriosis treatment MSN
Published: April 28, 2026, 10:38 p.m.
Is This The Part Of Endometriosis Treatment We’ve Been Missing? - MindBodyGreen
Is This The Part Of Endometriosis Treatment We’ve Been Missing? MindBodyGreen
Published: April 23, 2026, 4:14 p.m.
Australia's Cartherics expands agreement with Catalent to focus on cancer and endometriosis treatment - BioSpectrum Asia
Australia's Cartherics expands agreement with Catalent to focus on cancer and endometriosis treatment BioSpectrum Asia
Published: April 11, 2026, 7:52 a.m.
Endometriosis Treatments Market Size is Projected to Reach USD 6.53 Billion By 2035 – SNS Insider - Yahoo Finance
Endometriosis Treatments Market Size is Projected to Reach USD 6.53 Billion By 2035 – SNS Insider Yahoo Finance
Published: April 9, 2026, 12:30 p.m.
Hormone-Free Endometriosis Treatment: MSU Research Breakthrough - Michigan State University
Hormone-Free Endometriosis Treatment: MSU Research Breakthrough Michigan State University
Published: April 8, 2026, 2:09 p.m.
MSU researchers expand the search for hormone-free endometriosis treatments - Michigan State University
MSU researchers expand the search for hormone-free endometriosis treatments Michigan State University
Published: April 8, 2026, 2:09 p.m.
Why Endometriosis Treatment Fails 1 in 3 Women—And What's Next - MindBodyGreen
Why Endometriosis Treatment Fails 1 in 3 Women—And What's Next MindBodyGreen
Published: April 3, 2026, 9:27 a.m.
LG Chem Introduces Endometriosis Treatment 'Dinagest' from Japan's Mochida Pharmaceutical - 아시아경제
LG Chem Introduces Endometriosis Treatment 'Dinagest' from Japan's Mochida Pharmaceutical 아시아경제
Published: April 2, 2026, 11:40 p.m.
DKSH Thailand and Bayer Thai Expand Strategic Partnership to Broaden Access to Endometriosis Treatment - newswit
DKSH Thailand and Bayer Thai Expand Strategic Partnership to Broaden Access to Endometriosis Treatment newswit
Published: April 2, 2026, 2:01 p.m.
Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment - Femtech Insider
Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment Femtech Insider
Published: April 1, 2026, 11:54 a.m.
Link copied to clipboard!